17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
You can read Delaware's General Corporation Law front to back and back to front and still know very ...
Read More >
The ability to raise capital is one of the most critical challenges facing small businesses in the U...
Read More >
Pacta sunt servanda, i.e., agreements must be kept. This applies in both good economies and bad. Co...
Read More >
Various federal statutes contain whistleblower provisions that protect employees who raise or report...
Read More >
A Los Angeles jury awarded a black former UCLA phlebotomist nearly $1.6 million in damages for being...
Read More >
On May 21, the SEC finalized amendments to its rules and forms revising the disclosure requirements ...
Read More >